COMBINATION IRREVERSIBLE ELECTROPORATION AND ANTI-PD1 THERAPY REVERSES MDSC INDUCED IMMUNE-SUPPRESSIVE MICROENVIRONMENT IN HEPATOCELLULAR CARCINOMA.

被引：0
作者：
Huo, Jihui
Lei, Kai
Peng, Sui
Kuang, Ming
Dai, Zihao
Wang, Lina
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1550
引用
收藏
页码：S1725 / S1725
页数：1
相关论文
共 50 条
  • [31] Evaluation of Antitumor Immunity by a Combination Treatment of Radiation, Anti-PD1, and Anti-Angiogenic Therapy in Esophageal Squamous Cell Carcinoma
    Liu, Y.
    Li, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E247 - E247
  • [32] Quercetin/Anti-PD-1 Antibody Combination Therapy Regulates the Gut Microbiota, Impacts Macrophage Immunity and Reshapes the Hepatocellular Carcinoma Tumor Microenvironment
    Wu, Ruoxia
    Xiong, Jiaqing
    Zhou, Ting
    Zhang, Zhen
    Huang, Zhen
    Tian, Sha
    Wang, Yongli
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12):
  • [33] Tucatinib favourably modulates the immune microenvironment and synergises with anti-PD1 therapy in a trastuzumab resistant HER2+murine model
    Li, Ran
    Sant, Sneha
    Brown, Emmaline
    Caramia, Franco
    Byrne, Ann
    Clarke, Kylie
    Neeson, Michael
    Neeson, Paul J.
    Darcy, Phillip K.
    Peterson, Scott
    Loi, Sherene
    CANCER RESEARCH, 2021, 81 (04)
  • [34] β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
    de Galarreta, Marina Ruiz
    Bresnahan, Erin
    Molina-Sanchez, Pedro
    Lindblad, Katherine E.
    Maier, Barbara
    Sia, Daniela
    Puigvehi, Marc
    Miguela, Vernica
    Casanova-Acebes, Maria
    Dhainaut, Maxime
    Villacorta-Martin, Carlos
    Singhi, Aatur D.
    Moghe, Akshata
    von Felden, Johann
    Grinspan, Lauren Tal
    Wang, Shuang
    Kamphorst, Alice O.
    Monga, Satdarshan P.
    Brown, Brian D.
    Villanueva, Augusto
    Llovet, Josep M.
    Merad, Miriam
    Lujambio, Amaia
    CANCER DISCOVERY, 2019, 9 (08) : 1124 - 1141
  • [35] Immune cell dynamics of patients and mice with hepatocellular carcinoma treated with anti-PD-L1 plus anti-CTLA-4 combination therapy
    Myojin, Yuta
    Ruf, Benjamin
    Benmebarek, Mohamed-Reda
    Bauer, Kylynda
    Trehan, Rajiv
    Coffman, Kelley
    Ma, Chi
    Monge, Cecilia B.
    Xie, Changqing
    Greten, Tim
    CANCER RESEARCH, 2023, 83 (07)
  • [36] STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1
    Proia, Theresa A.
    Singh, Maneesh
    Woessner, Richard
    Carnevalli, Larissa
    Bommakanti, Gayathri
    Magiera, Lukasz
    Srinivasan, Srimathi
    Grosskurth, Shaun
    Collins, Mike
    Womack, Chris
    Griffin, Matthew
    Ye, Minwei
    Cantin, Susan
    Russell, Deanna
    Xie, Mingchao
    Hughes, Adina
    Deng, Nanhua
    Mele, Deanna A.
    Fawell, Stephen
    Barry, Simon
    Reimer, Corinne
    Barrett, J. Carl
    McCoon, Patricia
    CLINICAL CANCER RESEARCH, 2020, 26 (23) : 6335 - 6349
  • [37] Unraveling LGALS1 as a Potential Immune Checkpoint and a Predictor of the Response to Anti-PD1 Therapy in Clear Cell Renal Carcinoma
    Li, Yan
    Yang, Shouyan
    Yue, Honggang
    Yuan, Dandi
    Li, Luxia
    Zhao, Jinghong
    Zhao, Lintao
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1451 - 1458
  • [38] Huaier improves the efficacy of anti-PD-L1 Ab in the treatment of hepatocellular carcinoma by regulating tumor immune microenvironment
    Li, Huawei
    You, Jia
    Wei, Yuanfeng
    Zheng, Lingnan
    Yang, Ju
    Xu, Jingyi
    Li, Yue
    Li, Zhaojun
    Yang, Xi
    Yi, Cheng
    PHYTOMEDICINE, 2024, 123
  • [39] Blocking CX3CR1+ Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma
    Xiang, Xiaonan
    Wang, Kai
    Zhang, Hui
    Mou, Haibo
    Shi, Zhixiong
    Tao, Yaoye
    Song, Hongliang
    Lian, Zhengxing
    Wang, Shuai
    Lu, Di
    Wei, Xuyong
    Xie, Haiyang
    Zheng, Shusen
    Wang, Jianguo
    Xu, Xiao
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (11) : 1603 - 1620
  • [40] ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
    Li, Na
    Kang, Yuqi
    Wang, Lingling
    Huff, Sarah
    Tang, Rachel
    Hui, Hui
    Agrawal, Kriti
    Gonzalez, Gwendolyn Michelle
    Wang, Yinsheng
    Patel, Sandip Pravin
    Rana, Tariq M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (33) : 20159 - 20170
12345